Results
1 -
10 of
112Nicolas A. Stewart, Shama C. Buch, Thomas P. Conrads and Robert A. Branch.
A UPLC-MS/MS assay of the “Pittsburgh cocktail”: six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution, Analyst, 2011, 136, 605. All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes, Cancer Chemotherapy and Pharmacology Effects of Antimalarials on the Pharmacokinetics of Co-Administered Drugs, Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials Metabolism of diazepam and related benzodiazepines by human liver microsomes, European Journal of Drug Metabolism and Pharmacokinetics Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam, European Journal of Clinical Pharmacology Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans, Archives of Toxicology Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate, European Journal of Clinical Pharmacology Lack of effect of mianserin on the symptoms of diabetic neuropathy, European Journal of Clinical Pharmacology CYP2C19: The Support Crew II, A Case Approach to Perioperative Drug-Drug Interactions Genetic Polymorphism of Drug Metabolism in Humans, Biological Reactive Intermediates IV